Categories: News

Millennia welcomes Eric Ingram as its new Chief Financial Officer

RALEIGH, N.C., June 16, 2022 /PRNewswire/ — Millennia (the “Company”), a leader in patient payment and patient engagement for hospitals, health systems and medical groups, is excited to announce the addition of Eric Ingram as the new Chief Financial Officer. 

Eric comes to Millennia with more than 25 years of experience in financial leadership. He came to Millennia from the same role at Logitix, a leader in the sports and live events ticketing. Prior to Logitix, Eric served as CFO at TractManager where he played a key role in building the company from one standalone healthcare tech solution to a platform of six healthcare technology offerings used in over 3,000 hospitals. Much of Eric’s early career was spent in various offices and practices at PricewaterhouseCoopers. With a proven track record of success across multiple industries, Eric looks forward to helping Millennia in its next phase of growth. 

“We’re thrilled about the vision and growth of Millennia and that includes the addition of talented and passionate leaders,” said Scott Glass, Principal at Pamlico Capital. “Eric brings extensive experience growing and scaling healthcare technology companies and will be invaluable as we continue to build out the Millennia platform for the future.”

In addition to leading all aspects of finance, accounting and planning, Eric also oversees Human Resources and ensuring long-term and sustainable growth and success as an organization.

“In the short time Eric has been with Millennia, he has already proven himself to be a strategic leader and a change agent for our organization,” said Tom Ormondroyd, CEO of Millennia. “He brings a wealth of knowledge and expertise to our team with a focus on growth as a business while innovating for our clients and their patients. We’re excited to have Eric on the team as we continue our historic growth.”

About Millennia: Millennia is how healthcare providers engage with their patients – from the first appointment to the final payment. It means a better experience for your patients and more revenue for your organization. Founded in 2012, Millennia provides technology-driven patient pay and engagement solutions for more than 1,700 provider locations in 43 states, supporting over 40 million patient interactions every year. Millennia supports clients across all care settings including acute care, post-acute, medical groups and specialty practices. To learn more, visit Millenniapay.com.

Media Contact: Lisa Shackelford, 336-749-3012, lshackelford@millenniapay.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/millennia-welcomes-eric-ingram-as-its-new-chief-financial-officer-301568983.html

SOURCE Millennia

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

3 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

17 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

18 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

18 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

19 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

21 hours ago